Hedera Dx, founded in Switzerland in 2021, is dedicated to revolutionizing cancer care by providing advanced technology solutions that leverage molecular biology and artificial intelligence. The company aims to enhance access to sophisticated cancer care for the next billion people globally, utilizing tumor profiling, liquid biopsies, and real-world data insights to improve patient experiences and outcomes. With a team of 21 diverse professionals, Hedera Dx fosters a collaborative and inclusive culture, emphasizing mutual support and respect. The company is committed to innovation in precision oncology therapies and is looking for passionate individuals to join their mission-driven team.